Half of 'SARMs' sold online weren't what the label said
A 2017 JAMA study found only about half of products sold online as SARMs actually contained a SARM, and many held a different unapproved drug instead.
A 2017 JAMA study found only about half of products sold online as SARMs actually contained a SARM, and many held a different unapproved drug instead.

A peer-reviewed study published in JAMA in 2017 set out to see what was really inside products sold online as SARMs (selective androgen receptor modulators). The researchers — from the Sports Medicine Research and Testing Laboratory, the United States Anti-Doping Agency, Brigham and Women's Hospital, and the Uniformed Services University — bought 44 such products online and analyzed them using chain-of-custody handling and methods approved under World Anti-Doping Agency standards.
The results were striking. Only 23 of the 44 products (52%) contained one or more SARMs. Seventeen products (39%) contained a different, unapproved drug instead — among them ibutamoren, GW501516, and SR9009. Four products (9%) had no detectable active compound at all. In many cases the amount found did not match what the label claimed.
The pattern matters. A buyer who believes a label that says "SARM" may be receiving a different compound, a mis-dosed compound, or an inactive one — and would have no way to know without independent testing. The study is a direct illustration of why identity, content, and purity are separate questions: a product can contain the right molecule but at the wrong amount, or the wrong molecule entirely, and either failure is invisible to a label.
For our purposes the lesson is narrow and practical: label claims from online sellers are not results. They need to be checked against chromatography and mass spectrometry run on the actual sample, with a documented chain of custody. That is the gap a certificate of analysis is meant to close.
Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. JAMA. 2017;318(20):2004-2010. doi:10.1001/jama.2017.17069
Study2024Test purchases of online 'semaglutide' found purity around 7-14% against 99% advertised, wrong amounts, and elevated endotoxin in one sample.
Study2024How researchers map and audit an unregulated online peptide market, from search surveillance to lab testing.
Regulator2024The WHO estimates at least 1 in 10 medicines in low- and middle-income countries is substandard or falsified.